Target identification
Compound screening
Preclinical testing
We are dedicated to the very fine points of clinical research
Welcome to Eminat Research Group
We are committed to furthering the standard of medical knowledge by way of meticulous and insightful clinical research studies. We surpass current standards in excellence with a well-qualified group of investigators who take on studies of higher complexity and sophistication.
We are dedicated to the very fine points of clinical research and our depth of knowledge sets us apart. Our unparalleled pursuit of excellence is evident in our innovative strategy for designing and executing clinical trials that play a role in shaping the ever-changing healthcare
environment.
Come along with us on a journey toward where expertise meets innovation, and where dedication to excellence delivers breakthroughs that drive the stakes up in patient care. Eminat
Research Group – where knowledge like you’ve never witnessed shapes the future of clinical
research.
Advancing medicine,
innovating to improve lives
Clinical Research Studies
Sed ut perspiciatis unde
Quality Assurance
Quality Control
Our Biobank
Biorepositories are “libraries” in which biospecimens are stored for clinical or research purposes
Bioespecimen collections
(prospective, clinical remnants and banked)
Precision in Discovery. Compassion in Practice. Over 25 Years of Clinical Excellence Across Borders.
At Eminat, we don’t just conduct research—we shape the future of medicine. With more than 25 years of experience, a network of over 450,000 patients worldwide, and a reputation built on precision, ethics, and innovation, Eminat Research Group is a trusted partner for both patients and pharmaceutical companies.
From our headquarters in Miramar, Florida, we bridge communities and clinical advancements, offering a full spectrum of services—from biospecimen collection and biobank management to full-service clinical trial execution for complex studies.
Sandra V. Negrete
Founder and CEO of Eminat Research Group
Years of clinical research leadership
Global patient connections
Advanced biospecimen and biobank capabilities
Fully FDA, GCP, and compliant
Strategic partner for pharmaceutical, biotech & CROs
Bilingual staff and multicultural patient engagement
Have questions?
Get in touch!
News and insights
Top 5 challenges in modern drug discovery
From concept to cure: drug discovery steps
Emerging trends in targeted drug discovery
